Your shopping cart is currently empty

Synonyms: Urocortin (rat) acetate (171543-83-2 Free base)

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $159 | Inquiry | Inquiry | |
| 5 mg | $395 | Inquiry | Inquiry | |
| 10 mg | $563 | Inquiry | Inquiry | |
| 25 mg | $828 | Inquiry | Inquiry | |
| 50 mg | $1,130 | Inquiry | Inquiry | |
| 100 mg | $1,530 | Inquiry | Inquiry |
| Description | Urocortin (rat) acetate is a potent, selective CRFR agonist with Ki values of 13 nM, 1.5 nM, and 0.97 nM for human CRF1, rat CRF2α, and mouse CRF2β, respectively. Urocortin (rat) acetate exhibits cardioprotective, anti-inflammatory, and immunomodulatory activities. Urocortin (rat) acetate can be used in cardiovascular protection and immune-inflammatory research. |
| Targets & IC50 | CRF2α (rat):0.063 nM (EC50), CRF1 (human):0.15 nM (EC50), CRF2β (mouse):0.087 nM (EC50) |
| In vitro | Urocortin (rat) acetate induces cAMP generation with EC50 of 0.15 nM, 0.063 nM, and 0.087 nM for human CRF1, rat CRF2α and mouse CRF2β, respectively in stably transfected Chinese hamster ovary cells[1]. |
| In vivo | Urocortin (rat) acetate (0.01 to 10 μg) decreases food intake in both food-deprived and non-deprived rats and such an effect was observed in mice after Urocortin (1 μg; i.c.v.) administration[2]. |
| Synonyms | Urocortin (rat) acetate (171543-83-2 Free base) |
| Smiles | CC[C@@H]([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]1CCCN1C([C@@H]2CCCN2C([C@@H](NC([C@@H](N)CC(O)=O)=O)CC(O)=O)=O)=O)=O)CC(C)C)=O)CO)=O)[C@H](CC)C)=O)CC(O)=O)=O)CC(C)C)=O)[C@H](O)C)=O)CC3=CC=CC=C3)=O)CC4=CN=CN4)=O)CC(C)C)=O)CC(C)C)=O)CCCNC(N)=N)=O)[C@H](O)C)=O)CC(C)C)=O)CC(C)C)=O)CCC(O)=O)=O)CC(C)C)=O)C)=O)CCCNC(N)=N)=O)[C@H](O)C)=O)CCC(N)=O)=O)CO)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CCC(O)=O)=O)CCCNC(N)=N)=O)C)=O)CCC(O)=O)=O)CCC(N)=O)=O)CC(N)=O)=O)CCCNC(N)=N)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)C(C)C)=O)CO)=O)CC(O)=O)=O)CC5=CC=CC=C5)=O)[C@H](CC)C)=O)C.O=C(O)C |
| Relative Density. | no data available |
| Sequence | Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val |
| Sequence Short | DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV |
| Storage | Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.